Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new study, co-authored by Professor Vladyslav Vyazovskiy, published in Nature Neuroscience, has revealed that intracellular chloride levels within cortical pyramidal neurons reflect sleep–wake history.

The feeling of being tired is familiar to everyone. As we know from our own experience, an extended period of wakefulness results in a decline in our performance levels, and the desire to sleep becomes almost irresistible. When you then fall asleep, your sleep is deeper and more consolidated than usual. And yet after just one night of uninterrupted sleep, you can feel refreshed and “back to normal”!

Surprisingly, the cellular and neurobiological substrates of “sleep need” still remain elusive. Indeed, the way that the brain keeps track of waking activity in order to regulate sleep, is a long-sought goal in the field of neuroscience. A team of scientists at the University of Oxford, led by Professor Colin Akerman’s group (Department of Pharmacology), in collaboration with the Vyazovskiy group (DPAG) and the Bannerman group (Department of Experimental Psychology), have identified intracellular chloride regulation in the cerebral cortex as an essential part of the mechanism behind “tiredness”. Chloride is a negatively charged ion, essential for setting the electrical properties and excitability of neurons in the brain, but its role in sleep homeostasis has been previously overlooked. The paper is first authored by Dr Hannah Alfonsa and is published today in Nature Neuroscience.

The study reveals that intracellular chloride levels within cortical pyramidal neurons reflect the animal’s sleep–wake history. Chloride levels are low after a period of sleep, but increase after a period of wakefulness. Furthermore, chloride levels are shown to reflect the level of brain activity, with higher intracellular chloride being found in brain regions that were more active during wakefulness. The significance of these changes is that elevated intracellular chloride weakens inhibitory synaptic transmission in the cortex. Indeed, the high chloride is shown to increase the synchrony of action potentials amongst nearby neurons, which produces the high slow wave activity observed in non rapid eye movement sleep – an electrophysiological marker of intense, restorative sleep. More excitingly, pharmacological manipulations of chloride levels were found to be sufficient to correct the drop in cognitive performance levels in sleep-deprived animals, providing a research avenue to restore performance levels when we are tired.

Professor Colin Akerman comments: “These findings reveal an unexpected role for ion regulatory mechanisms in the brain, and identify intracellular chloride and synaptic inhibition as key cellular changes underlying tiredness. The findings also provide a new context for understanding sleep and cognitive disturbances associated with conditions such as epilepsy, autism, and schizophrenia, in which altered chloride regulation has been reported in the cortex.”

Dr Hannah Alfonsa adds: “Only a small proportion of neuroscience research takes into account the sleep-wake history of laboratory animals, but our findings suggest that this is important for understanding something as fundamental as synaptic inhibition. We hope that our findings will provide further motivation to not only target chloride regulatory mechanisms as a treatment strategy, but also to account for sleep-wake history in order to improve therapeutic effects.”

Professor Vladyslav Vyazovskiy, who is also a member of the Sir Jules Thorn Sleep and Circadian Neuroscience Institute and the Kavli Institute for Nanoscience Discovery, mentions: “The notion that sleep is not only a global state of the organism but is regulated at the level of local brain circuits has provided a new appreciation of the effects of sleep deprivation, for example in shift-workers or in sleep disorders such as insomnia or sleep-walking. However, the neurophysiological substrates of local sleep regulation remained elusive for decades. This work suggests a novel and highly promising mechanism that links cellular processes with changes in behaviour, associated with sleep loss.”

"Over the last 10 years 'neuroscience of sleep' became one of the flagship research directions in Oxford, with many groups across DPAG, SCNi and other departments, units and institutions collaborating actively in this field. I am very lucky to be involved in some of those projects, where we are joining efforts with colleagues neuroscientists working on a wide range of projects and using a variety of cutting edge techniques, to tackle some of the most burning questions about sleep from new and original angles. It results in very exciting discoveries like this one." 

The full paper “Intracellular chloride regulation mediates local sleep pressure in the cortex” is now available to read in Nature Neuroscience.

Similar stories

New insights into chemogenetic designer drugs to enhance our study of behaviour

A collaborative team of researchers in DPAG and Pharmacology led by Dr Lukas Krone have uncovered striking new data demonstrating that two widely used designer drugs used to turn populations of neurons on and off in the brain cause unexpected effects on sleep. These results demonstrate a critical need to improve chemogenetic approaches in behavioural studies.

Ensuring LGBTQI+ people are treated fairly in mental health data

Andrey Kormilitzin outlines a new participatory study aimed at improving AI to take account of LGBTQI+ people so that their needs are better met by mental health services.

Community play packs inspire families to be more playful at home

A project led by Alex Hendry working with Oxford Brookes has engaged with parents and early years practitioners in a bid to help families spend more time playing with their children.

Major trials to test effectiveness of cannabidiol on psychosis

Global study involving three clinical trials will investigate the effectiveness of cannabidiol (CBD) in treating people with psychosis or psychotic symptoms, thanks to a multi-million pound grant to Oxford University.

Friendship and mental health in adolescents

Tanya Manchanda's new paper investigates the role of friendship on the mental health outcomes of adolescents